Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000337866 | SCV000369899 | likely benign | Maturity onset diabetes mellitus in young | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000401881 | SCV000369900 | likely benign | Transient Neonatal Diabetes, Dominant/Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000353899 | SCV000483265 | benign | Autosomal recessive DOPA responsive dystonia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001660593 | SCV001874655 | benign | not provided | 2018-09-04 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 16380501, 20628762, 19247282) |
Clinical Genomics, |
RCV003463781 | SCV004190178 | uncertain significance | Maturity-onset diabetes of the young type 10 | criteria provided, single submitter | research | Potent mutations in INS gene can cause early onset diabetes mellitus which is insulin dependent. May have poor response to sulfonylureas, as mutations in this gene can cause beta cell destruction. However no sufficient evidence is found to ascertain the role of this particular variant rs3842740, yet. |